» Articles » PMID: 17014551

Can Acidosis and Hyperphosphataemia Result in Increased Erythropoietin Dosing in Haemodialysis Patients?

Overview
Specialty Nephrology
Date 2006 Oct 4
PMID 17014551
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: To evaluate whether factors such as acidosis and hyperphosphataemia that might cause an increased oxygen delivery to tissues could result in increased dosing requirements for intravenous erythropoietin (EPO) administration given to haemodialysis patients.

Methods: The clinical records of the patients seen at the Hypertension, Nephrology, Dialysis and Transplantation Clinic from December, 2004 through August, 2005 were reviewed to identify patients who had taken intravenous erythropoietin. Two-tailed, Pearson's correlation was performed to determine correlations between any of the parameters. Analysis of variance and stepwise regression for covariance were used to evaluate the relations of demographic and clinical characteristics and laboratory variables. Analysis of covariance and K means cluster analyses were also performed to examine linkage between variables. Kendall's Tau correlation was used for correlations of non-parametric data.

Results: There was a significant direct or positive correlation at the 0.01 levels between dry weight, age, intact parathyroid hormone level (PTH), and serum phosphorus and EPO dose. There was an inverse or negative correlation at that level between the serum bicarbonate and urea reduction ratio (URR) with the EPO dose at the same level while there was a weaker correlation but direct correlation between the white blood count (WBC) and EPO dose. There was significant colinearity between serum phosphorus and PTH but serum phosphorus showed a more significant correlation with EPO overall. Stepwise regression analysis for covariance revealed that phosphorus remained significantly correlated with EPO resistance after the removal of the effect of PTH while PTH lost its significance after the effect of phosphorus was removed.

Conclusion: Acidosis and hyperphosphataemia are associated with apparent increased erythropoietin dosing requirements. While this study did not evaluate the mechanism of such requirements and indeed many mechanisms might be possible, a rightward shift in the oxygen-haemoglobin dissociation curve resulting in down-regulation of erythropoietin receptors is considered consistent with the data and present knowledge.

Citing Articles

Impact of Serum Phosphate on Hemoglobin Level: A Longitudinal Analysis on a Large Cohort of Dialysis Patients.

Calabrese V, Tripepi G, Santoro D, Cernaro V, Panuccio V, Mezzatesta S J Clin Med. 2024; 13(19).

PMID: 39407717 PMC: 11477030. DOI: 10.3390/jcm13195657.


Serum Phosphate Levels Modify the Impact of FGF23 Levels on Hemoglobin in Chronic Kidney Disease.

Navarro-Gonzalez J, Mora-Fernandez C, Diaz-Tocados J, Bozic M, Bermudez-Lopez M, Martin M Nutrients. 2022; 14(22).

PMID: 36432528 PMC: 9698012. DOI: 10.3390/nu14224842.


Impact of Metabolic Acidosis and Alkali Therapy on Linear Growth in Children with Chronic Kidney Disease: What Is the Current Evidence?.

Ulrich E, Chanchlani R Kidney360. 2022; 3(4):590-596.

PMID: 35721614 PMC: 9136911. DOI: 10.34067/KID.0000072022.


Effects of Oral Bicarbonate Supplementation on the Cardiovascular Risk Factors and Serum Nutritional Markers in Non-Dialysed Chronic Kidney Disease Patients.

Szczecinska K, Wajdlich M, Nowicka M, Nowicki M, Kurnatowska I Medicina (Kaunas). 2022; 58(4).

PMID: 35454357 PMC: 9027759. DOI: 10.3390/medicina58040518.


Metabolic Acidosis in Patients with CKD: Epidemiology, Pathogenesis, and Treatment.

Adamczak M, Surma S Kidney Dis (Basel). 2021; 7(6):452-467.

PMID: 34901192 PMC: 8613635. DOI: 10.1159/000516371.